By www.reliablemarketsize.com
Global And United States Receptor Tyrosine Protein Kinase ERBB 3 Market Report & Forecast 2024-2031 Story
119
$ 4350
Receptor Tyrosine Protein Kinase ERBB 3 Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
AstraZeneca Plc AVEO Pharmaceuticals, Inc. Etubics Corporation F. Hoffmann-La Roche Ltd. GamaMabs Pharma S.A. GlaxoSmithKline Plc Hanmi Pharmaceuticals, Co. Ltd. ImmunoGen, Inc. Kolltan Pharmaceuticals, Inc. Merrimack Pharmaceuticals, Inc. Merus B.V. Novartis AG Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Sihuan Pharmaceutical Holdings Group Ltd. Sorrento Therapeutics, Inc. Symphogen A/S Takis S.r.l.